Therapeutic Antibody discovery platform
Millegen is expert in discovery and genetic engineering of therapeutic antibodies. MilleGen’s antibody platform allows the generation of fully human monoclonal antibodies and lead optimization using our powerful Directed Molecular Evolution technology (Mutagen). Our specificity is to have a proprietary library comprising several billion different fully human antibodies with an original diversity. Our efficiency was proven through several successful projects with industrial partners. We are proposing to associate human antibody candidates to your original targets to develop with you a targeted therapy.
VALIDATED PLATFORM:
- Fully human antibody selection
- Successful projects delivered on time
- Highly skilled and experienced scientific team
- Screening designed to your target specificity
- Independent company: proprietary human antibody library
- Original diversity of the library
- 11 years of experience in biotechnology
